Delayed
OTC Markets
15:50:23 2024-05-20 EDT
|
5-day change
|
1st Jan Change
|
0.0004
USD
|
0.00%
|
|
+33.33%
|
+33.33%
|
Fiscal Period: December |
2018
|
2019
|
2020
|
2021
|
2022
|
2023
|
---|
Capitalization
1 |
10.43
|
0.4274
|
7.095
|
3.579
|
1.492
|
1.119
|
Enterprise Value (EV)
1 |
21.69
|
10.35
|
15.49
|
15.03
|
12.78
|
15.63
|
P/E ratio
|
-1.2
x
|
-0.03
x
|
2.36
x
|
-1.64
x
|
10.8
x
|
1.04
x
|
Yield
|
-
|
-
|
-
|
-
|
-
|
-
|
Capitalization / Revenue
|
24.1
x
|
1.19
x
|
20.9
x
|
1.84
x
|
0.31
x
|
0.21
x
|
EV / Revenue
|
50.1
x
|
28.8
x
|
45.7
x
|
7.74
x
|
2.65
x
|
2.92
x
|
EV / EBITDA
|
-8.31
x
|
-2.77
x
|
-368
x
|
45.9
x
|
12.4
x
|
-364
x
|
EV / FCF
|
11.1
x
|
3.53
x
|
-3.89
x
|
-3.28
x
|
-1,346
x
|
-2.76
x
|
FCF Yield
|
8.98%
|
28.3%
|
-25.7%
|
-30.5%
|
-0.07%
|
-36.2%
|
Price to Book
|
-1.35
x
|
-0.02
x
|
-0.49
x
|
-0.33
x
|
-0.15
x
|
-0.18
x
|
Nbr of stocks (in thousands)
|
124,189
|
147,384
|
2,027,086
|
3,579,054
|
3,729,054
|
3,729,054
|
Reference price
2 |
0.0840
|
0.002900
|
0.003500
|
0.001000
|
0.000400
|
0.000300
|
Announcement Date
|
4/16/19
|
7/10/20
|
4/15/21
|
4/14/22
|
3/31/23
|
5/7/24
|
Fiscal Period: December |
2018
|
2019
|
2020
|
2021
|
2022
|
2023
|
---|
Net sales
1 |
0.4325
|
0.3599
|
0.339
|
1.943
|
4.821
|
5.345
|
EBITDA
1 |
-2.611
|
-3.74
|
-0.0421
|
0.3275
|
1.029
|
-0.043
|
EBIT
1 |
-2.884
|
-3.957
|
-0.1633
|
0.002105
|
0.4891
|
-0.5419
|
Operating Margin
|
-666.87%
|
-1,099.39%
|
-48.18%
|
0.11%
|
10.15%
|
-10.14%
|
Earnings before Tax (EBT)
1 |
-8.076
|
-14.96
|
3.085
|
-1.854
|
0.4074
|
0.6145
|
Net income
1 |
-8.179
|
-14.96
|
3.085
|
-1.543
|
0.2479
|
1.177
|
Net margin
|
-1,890.95%
|
-4,156.96%
|
910.04%
|
-79.43%
|
5.14%
|
22.01%
|
EPS
2 |
-0.0700
|
-0.1099
|
0.001482
|
-0.000608
|
0.000037
|
0.000289
|
Free Cash Flow
1 |
1.947
|
2.933
|
-3.98
|
-4.587
|
-0.009497
|
-5.661
|
FCF margin
|
450.14%
|
814.92%
|
-1,173.99%
|
-236.11%
|
-0.2%
|
-105.91%
|
FCF Conversion (EBITDA)
|
-
|
-
|
-
|
-
|
-
|
-
|
FCF Conversion (Net income)
|
-
|
-
|
-
|
-
|
-
|
-
|
Dividend per Share
|
-
|
-
|
-
|
-
|
-
|
-
|
Announcement Date
|
4/16/19
|
7/10/20
|
4/15/21
|
4/14/22
|
3/31/23
|
5/7/24
|
Fiscal Period: December |
2018
|
2019
|
2020
|
2021
|
2022
|
2023
|
---|
Net Debt
1 |
11.3
|
9.93
|
8.39
|
11.5
|
11.3
|
14.5
|
Net Cash position
1 |
-
|
-
|
-
|
-
|
-
|
-
|
Leverage (Debt/EBITDA)
|
-4.312
x
|
-2.654
x
|
-199.5
x
|
34.98
x
|
10.97
x
|
-337.5
x
|
Free Cash Flow
1 |
1.95
|
2.93
|
-3.98
|
-4.59
|
-0.01
|
-5.66
|
ROE (net income / shareholders' equity)
|
172%
|
108%
|
-17.8%
|
13.1%
|
-3.23%
|
-13.4%
|
ROA (Net income/ Total Assets)
|
-14.5%
|
-31.1%
|
-2.9%
|
0.03%
|
4.66%
|
-3.75%
|
Assets
1 |
56.57
|
48.04
|
-106.3
|
-6,099
|
5.318
|
-31.41
|
Book Value Per Share
2 |
-0.0600
|
-0.1300
|
-0.0100
|
-0
|
-0
|
-0
|
Cash Flow per Share
2 |
0
|
0
|
0
|
0
|
0
|
0
|
Capex
1 |
0.32
|
0.1
|
-
|
0.13
|
0.32
|
5.25
|
Capex / Sales
|
74.01%
|
26.46%
|
-
|
6.84%
|
6.55%
|
98.22%
|
Announcement Date
|
4/16/19
|
7/10/20
|
4/15/21
|
4/14/22
|
3/31/23
|
5/7/24
|
|
1st Jan change
|
Capi.
|
---|
| +33.33% | 1.49M | | +17.71% | 85.14B | | -27.52% | 72.06B | | +2.75% | 27.07B | | -9.55% | 17.43B | | -1.96% | 16.98B | | +3.80% | 16.02B | | +7.51% | 13.87B | | +70.19% | 13.06B | | +72.93% | 12.79B |
Other Healthcare Facilities & Services
|